Search

everythinglearnresearchcommunity

for

Search:↓

Energy healing treatment improved flutamide's solubility and stability, potentially enhancing its effectiveness for prostate cancer.

Finasteride may cause sexual and psychological side effects by affecting an enzyme related to epinephrine.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Nanoparticles improve drug delivery and effectiveness in treating inflamed skin.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Minoxidil use increases facial hair growth in females, more in older users.

Clascoterone cream was approved in the USA for treating acne in people aged 12 and older.

The spironolactone cream did not reduce hair growth in women with hirsutism.

Centipeda minima extract helps hair grow by activating important growth signals and could be a promising hair loss treatment.

MK-386 and finasteride together effectively reduce DHT levels, potentially treating acne and male pattern baldness.

A new, efficient method has been developed to detect darolutamide and thalidomide, drugs used for certain hair loss and prostate cancer treatments, in pharmaceuticals and body fluids.

Low dose valproic acid treatment caused hair loss in a young patient.

Hair follicles have a pH gradient, increasing towards the root.

Minoxidil absorption in skin is slowed by cleansing, depends on how long it stays on the skin, and is not much affected by reapplication.

Hair follicles help absorb and store topical compounds, aiding targeted drug delivery.

Taxol damages hair growth cells, causing hair loss.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Combination drug therapies are more effective for high-risk BPS patients but have more side effects and costs.

The new drug delivery systems made with surfactants and block polymers are stable and not toxic.

Latanoprost, a glaucoma drug, showed potential for promoting hair growth in bald monkeys, especially at higher doses.

Platelet-rich plasma can temporarily inhibit some drug-resistant bacteria in diabetic foot infections.

Hair color loss can indicate the effectiveness of a drug targeting the KIT protein in mice and humans.

Human hair-derived particles can effectively carry and release the cancer drug Paclitaxel in a pH-sensitive manner, potentially targeting cancer cells while sparing healthy ones.

Finasteride, a drug, can block the seizure-preventing effects of a hormone called progesterone in mice.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

Treprostinil, a drug, can delay wound healing in healthy cells but doesn't affect diabetic foot ulcer cells, suggesting further research could help understand its role in treating these ulcers.

Many medications can cause hair loss or excessive hair growth, which is usually reversible after stopping the drug.

Boron/nitrogen-doped carbon nano-onions improve targeted breast cancer treatment by enhancing drug delivery and reducing side effects.

Human hair follicles can be used to create skin-like tissue for wound healing and drug testing.